BR9809117A - Composição de gel retardado de liberação prolongada, processo de produzir a mesma, formulação farmacêutica,e , processos de tratamento de uma indicação , de uma doença, e de uma inflamação com uma composição de liberação prolongada - Google Patents
Composição de gel retardado de liberação prolongada, processo de produzir a mesma, formulação farmacêutica,e , processos de tratamento de uma indicação , de uma doença, e de uma inflamação com uma composição de liberação prolongadaInfo
- Publication number
- BR9809117A BR9809117A BR9809117-4A BR9809117A BR9809117A BR 9809117 A BR9809117 A BR 9809117A BR 9809117 A BR9809117 A BR 9809117A BR 9809117 A BR9809117 A BR 9809117A
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- processes
- inflammation
- disease
- indication
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
"COMPOSIçãO DE GEL RETARDADO DE LIBERAçãO PROLONGADA, PROCESSO DE PRODUZIR A MESMA, FORMULAçãO FARMACêUTICA, E, PROCESSOS DE TRATAMENTO DE UMA INDICAçãO, DE UMA DOENçA, E DE UMA INFLAMAçãO COM UMA COMPOSIçãO DE LIBERAçàO PROLONGADA". A presente invenção diz respeito a formulações de liberação prolongada, usando-se géis retardados de alginato, e seus processos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85797397A | 1997-05-16 | 1997-05-16 | |
US91290297A | 1997-08-15 | 1997-08-15 | |
PCT/US1998/010013 WO1998051348A2 (en) | 1997-05-16 | 1998-05-18 | Sustained-release delayed gels |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9809117A true BR9809117A (pt) | 2000-08-01 |
Family
ID=27127437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9809117-4A BR9809117A (pt) | 1997-05-16 | 1998-05-18 | Composição de gel retardado de liberação prolongada, processo de produzir a mesma, formulação farmacêutica,e , processos de tratamento de uma indicação , de uma doença, e de uma inflamação com uma composição de liberação prolongada |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0981374B1 (pt) |
JP (1) | JP2001525826A (pt) |
KR (1) | KR20010012374A (pt) |
AU (1) | AU7491898A (pt) |
BG (1) | BG64860B1 (pt) |
BR (1) | BR9809117A (pt) |
CA (1) | CA2289196C (pt) |
CZ (1) | CZ299180B6 (pt) |
DE (1) | DE69838750T2 (pt) |
EA (1) | EA199901013A1 (pt) |
ES (1) | ES2294814T3 (pt) |
HU (1) | HUP0003393A3 (pt) |
IL (1) | IL132814A0 (pt) |
NO (1) | NO995591D0 (pt) |
PL (1) | PL199565B1 (pt) |
SK (1) | SK286437B6 (pt) |
WO (1) | WO1998051348A2 (pt) |
YU (1) | YU58599A (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003200609B2 (en) * | 1998-05-18 | 2006-02-23 | Amgen Inc. | Biodegradable sustained-release alginate gels |
US6432449B1 (en) * | 1998-05-18 | 2002-08-13 | Amgen Inc. | Biodegradable sustained-release alginate gels |
JP2000256216A (ja) * | 1999-03-04 | 2000-09-19 | Meiji Milk Prod Co Ltd | ゲル組成物 |
US7582311B1 (en) | 1999-10-15 | 2009-09-01 | Genentech, Inc. | Injection vehicle for polymer-based formulations |
US7651703B2 (en) | 1999-10-15 | 2010-01-26 | Genentech, Inc. | Injection vehicle for polymer-based formulations |
AU1931801A (en) * | 1999-11-29 | 2001-06-04 | Advanced Research And Technology Institute, Inc. | Sustained percutaneous delivery of a biologically active substance |
FR2823119B1 (fr) * | 2001-04-05 | 2004-02-20 | Seppic Sa | Adjuvant d'immunite contenant un cation metallique complexe et vaccin le contenant |
KR20050071611A (ko) * | 2002-10-25 | 2005-07-07 | 화이자 프로덕츠 인코포레이티드 | 현탁액 형태의 아릴헤테로환 활성제의 저장 제형 |
JP5336180B2 (ja) * | 2005-05-23 | 2013-11-06 | ナチュラル オータナティブス インターナショナル | β−アラニンの徐放のための組成物及び方法 |
US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
JP5107585B2 (ja) * | 2007-01-29 | 2012-12-26 | 株式会社 メドレックス | 低温充填ゼリー組成物とその製造方法 |
EP1985286A1 (en) * | 2007-04-24 | 2008-10-29 | Biocompatibles UK Limited | Microspheres for treatment of brain tumours |
BR112013009205A2 (pt) | 2010-10-15 | 2016-07-26 | Iscience Interventional Corp | dispositivo para colocação na esclera de um olho, método para acessar o espaço supracoroidal de um olho, para acessar o espaço subretinal de um olho e para colocar um orifício dentro de um trato escleral em um olho. |
JP6487848B2 (ja) | 2012-11-08 | 2019-03-20 | クリアサイド バイオメディカル,インコーポレイテッド | ヒト被験体における眼部障害の処置のための方法およびデバイス |
BR112015027762A2 (pt) | 2013-05-03 | 2017-08-29 | Clearside Biomedical Inc | Aparelho e métodos para injeção ocular |
US10010447B2 (en) | 2013-12-18 | 2018-07-03 | Novartis Ag | Systems and methods for subretinal delivery of therapeutic agents |
JP2017524419A (ja) | 2014-06-20 | 2017-08-31 | クリアサイド バイオメディカル,インコーポレイテッド | 薬剤送達のための挿入深さを制御するための可変径カニューレ及び方法 |
WO2017139375A1 (en) | 2016-02-10 | 2017-08-17 | Clearside Biomedical, Inc. | Ocular injection kit, packaging, and methods of use |
WO2017192565A1 (en) | 2016-05-02 | 2017-11-09 | Clearside Biomedical, Inc. | Systems and methods for ocular drug delivery |
US10973681B2 (en) | 2016-08-12 | 2021-04-13 | Clearside Biomedical, Inc. | Devices and methods for adjusting the insertion depth of a needle for medicament delivery |
EP3644729A1 (en) * | 2018-06-04 | 2020-05-06 | Spermvital AS | Functionalized kit for preparing hydrogels |
WO2020096281A1 (ko) | 2018-11-06 | 2020-05-14 | 국립암센터 | 알긴산 기반의 주입형 수화젤 시스템 |
US20220257637A1 (en) * | 2019-10-01 | 2022-08-18 | Brillian Pharma Inc. | Methods for treating or preventing obesity and body weight management |
CN114533653B (zh) * | 2020-11-26 | 2023-12-22 | 上海凯茂生物医药有限公司 | 一种人促红素杂合Fc融合蛋白相变型制剂及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5416979B2 (pt) * | 1972-01-08 | 1979-06-26 | ||
US4241099A (en) * | 1979-02-26 | 1980-12-23 | Tiemstra Peter J | Pectin formulations, products and methods having delayed-action acidulants |
US4789516A (en) * | 1983-04-15 | 1988-12-06 | Damon Biotech, Inc | Production of sustained released system |
US4690682A (en) * | 1983-04-15 | 1987-09-01 | Damon Biotech, Inc. | Sustained release |
US4744933A (en) * | 1984-02-15 | 1988-05-17 | Massachusetts Institute Of Technology | Process for encapsulation and encapsulated active material system |
CA1215922A (en) * | 1984-05-25 | 1986-12-30 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
JPS645460A (en) * | 1987-06-29 | 1989-01-10 | Sanei Kagaku Kogyo Kk | Production of delaying gelatinous material |
JPH0794583B2 (ja) * | 1989-12-15 | 1995-10-11 | 株式会社大塚製薬工場 | 高含水高分子ゲル |
IT1245383B (it) * | 1991-03-28 | 1994-09-20 | Eniricerche Spa | Composizione acquosa gelificabile avente tempo di gelificazione ritardato |
US5711968A (en) * | 1994-07-25 | 1998-01-27 | Alkermes Controlled Therapeutics, Inc. | Composition and method for the controlled release of metal cation-stabilized interferon |
KR960006730B1 (ko) * | 1993-02-11 | 1996-05-23 | 재단법인한국화학연구소 | 에멀젼 네트웍(emulsion network)을 이용한 약물의 피부 전달체계 |
GB9708773D0 (en) * | 1997-04-30 | 1997-06-25 | Reckitt & Colmann Prod Ltd | Organic compositions |
-
1998
- 1998-05-18 ES ES98922348T patent/ES2294814T3/es not_active Expired - Lifetime
- 1998-05-18 CA CA002289196A patent/CA2289196C/en not_active Expired - Fee Related
- 1998-05-18 SK SK1543-99A patent/SK286437B6/sk not_active IP Right Cessation
- 1998-05-18 HU HU0003393A patent/HUP0003393A3/hu unknown
- 1998-05-18 EP EP98922348A patent/EP0981374B1/en not_active Expired - Lifetime
- 1998-05-18 PL PL336887A patent/PL199565B1/pl unknown
- 1998-05-18 AU AU74918/98A patent/AU7491898A/en not_active Abandoned
- 1998-05-18 IL IL13281498A patent/IL132814A0/xx unknown
- 1998-05-18 DE DE69838750T patent/DE69838750T2/de not_active Expired - Fee Related
- 1998-05-18 YU YU58599A patent/YU58599A/sh unknown
- 1998-05-18 EA EA199901013A patent/EA199901013A1/ru unknown
- 1998-05-18 CZ CZ0396399A patent/CZ299180B6/cs not_active IP Right Cessation
- 1998-05-18 BR BR9809117-4A patent/BR9809117A/pt not_active Application Discontinuation
- 1998-05-18 KR KR1019997010326A patent/KR20010012374A/ko not_active Application Discontinuation
- 1998-05-18 JP JP54960298A patent/JP2001525826A/ja not_active Ceased
- 1998-05-18 WO PCT/US1998/010013 patent/WO1998051348A2/en active IP Right Grant
-
1999
- 1999-11-15 NO NO995591A patent/NO995591D0/no not_active Application Discontinuation
- 1999-11-23 BG BG103914A patent/BG64860B1/bg unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0003393A2 (hu) | 2001-02-28 |
AU7491898A (en) | 1998-12-08 |
NO995591L (no) | 1999-11-15 |
DE69838750T2 (de) | 2008-10-30 |
DE69838750D1 (de) | 2008-01-03 |
BG64860B1 (bg) | 2006-07-31 |
CA2289196A1 (en) | 1998-11-19 |
YU58599A (sh) | 2000-12-28 |
JP2001525826A (ja) | 2001-12-11 |
PL199565B1 (pl) | 2008-10-31 |
SK286437B6 (sk) | 2008-10-07 |
EP0981374A2 (en) | 2000-03-01 |
SK154399A3 (en) | 2000-07-11 |
KR20010012374A (ko) | 2001-02-15 |
CZ396399A3 (cs) | 2000-04-12 |
ES2294814T3 (es) | 2008-04-01 |
WO1998051348A2 (en) | 1998-11-19 |
WO1998051348A3 (en) | 1999-02-18 |
PL336887A1 (en) | 2000-07-17 |
EP0981374B1 (en) | 2007-11-21 |
CZ299180B6 (cs) | 2008-05-14 |
NO995591D0 (no) | 1999-11-15 |
HUP0003393A3 (en) | 2001-03-28 |
CA2289196C (en) | 2007-08-07 |
IL132814A0 (en) | 2001-03-19 |
EA199901013A1 (ru) | 2000-06-26 |
BG103914A (en) | 2000-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9809117A (pt) | Composição de gel retardado de liberação prolongada, processo de produzir a mesma, formulação farmacêutica,e , processos de tratamento de uma indicação , de uma doença, e de uma inflamação com uma composição de liberação prolongada | |
BRPI9908182B8 (pt) | composições de proteína de matriz para cura de feridas | |
BR9812339A (pt) | Processo para branquear os dentes, e, composição de higiene oral para branqueamento do dente | |
UA41989C2 (uk) | Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри | |
UA56989C2 (uk) | ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ | |
BR9406363A (pt) | Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico | |
BG101118A (en) | Therapeutical compounds | |
AU9125798A (en) | Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses | |
BR0115531A (pt) | Tratamento de mucosites | |
CA2293470A1 (en) | Benzimidazole derivatives | |
ES2163034T3 (es) | Composiciones micelares de copolimeros de bloque de polieter, para la objetivizacion de agentes biologicos como diana. | |
CA2289717A1 (en) | Novel therapy for constipation | |
BR0112962A (pt) | Composições farmacêuticas para o tratamento de condições inflamatórias e ulcerativas dolorosas de maioria das superfìcies epiteliais tais como mucosite, estomatite e sìndrome de behcet | |
BR9811086A (pt) | Utilização de preparados de eritropoietina e ferro, processo para a produção de um preparado de combinação farmacêutica e embalagem unitária farmacêutica | |
HK1030880A1 (en) | Matrix protein compositions for wound healing | |
HUP9602498A2 (hu) | Antimikrobiális hatású gyógyászati készítmények | |
EA199700380A1 (ru) | Бициклические ароматические соединения, фармацевтическая и косметическая композиции на их основе и применение косметической композиции | |
DE58902712D1 (de) | N-acetylglucosamin-zubereitungen zur buccalen anwendung. | |
TR200002078T2 (tr) | Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar. | |
EA199700381A1 (ru) | Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций | |
BR9914848A (pt) | Composição e processo para o tratamento de distúrbios da retina externa | |
ITRM930291A0 (it) | Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti. | |
NO172043C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater | |
PT1007040E (pt) | Utilizacao de fanquinona no tratamento da doenca de alzheimer | |
HUP9902135A2 (hu) | (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART 36 DA LPI (LEI 9.279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. |